Latest Form 144 filings
Officers, directors and other affiliates of a company file Form 144 when they place an order to sell restricted or control shares, if they plan to sell more than 5,000 shares or more than $50,000 worth within three months. It is a notice of a planned sale; officers and directors report the sale itself later on Form 4. 13D, 13G and Form 144 explained
Form 144 notices
Newest first. When a Form 144/A amends a notice, only the amendment is listed.
Filed in the last 365 days (US Eastern dates).
Form 144 filings on Livermore: Jan 4, 2023 to Sep 29, 2026.
Notices with a clearly misreported market value are left out of this list and its totals; they still appear, flagged, on the company's page. A value counts as misreported when the price per share it implies is far above the company's prices in Form 4 trades and 13F filings around the planned sale date.
- Notices
- 418
- Market value to sell
- $1.41B
- Sellers
- 117
- Companies
- 37
- Under 10b5-1 plans
- 224
| Company | Filed (ET) | Seller | Shares to sell | Market value | Planned sale | Broker | Filing |
|---|---|---|---|---|---|---|---|
| ARQTArcutis Biotherapeutics, Inc. | Oct 1, 20253:16 PM ET | Howard WelgusDirector | 10.0K | $189.2K | Oct 1, 202510b5-1 | Merrill | SEC |
| VIRVir Biotechnology, Inc. | Oct 1, 20254:32 PM ET | Vicki Lee SatoDirector | 66.0K | $376.9K | Oct 1, 202510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| IOTSamsara Inc. | Oct 1, 20254:36 PM ET | Dominic PhillipsOfficer | 55.6K | $2.07M | Oct 1, 202510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| ARQTArcutis Biotherapeutics, Inc. | Oct 1, 20255:35 PM ET | Todd Franklin WatanabeOfficer | 24.3K | $469.1K | Oct 1, 202510b5-1 | Merrill Lynch | SEC |
| ARQTArcutis Biotherapeutics, Inc. | Oct 2, 20254:41 PM ET | Larry Todd EdwardsOfficer | 4.50K | $90.3K | Oct 2, 2025 | Merrill | SEC |
| ARQTArcutis Biotherapeutics, Inc. | Oct 2, 20254:43 PM ET | Todd Franklin WatanabeOfficer | 20.7K | $415.6K | Oct 2, 202510b5-1 | Merrill Lynch | SEC |
| PTCTPTC Therapeutics, Inc. | Oct 3, 20254:40 PM ET | Boulding Mark ElliottOfficer | 22.7K | $1.49M | Oct 3, 202510b5-1 | Fidelity Brokerage Services LLC | SEC |
| VIRVir Biotechnology, Inc. | Oct 3, 20255:00 PM ET | SVF Endurance (Cayman) Limited10% stockholder | 1.67M | $9.53M | Oct 3, 202510b5-1 | BTIG, LLC | SEC |
| AXSMAxsome Therapeutics, Inc. | Oct 6, 20254:47 PM ET | Herriot TabuteauOfficer | 19.2K | $2.31M | Oct 6, 202510b5-1 | Goldman Sachs & Co. LLC | SEC |
| PTCTPTC Therapeutics, Inc. | Oct 6, 20255:16 PM ET | Boulding Mark ElliottOfficer | 2.27K | $147.5K | Oct 6, 202510b5-1 | Fidelity Brokerage Services LLC | SEC |
| PTCTPTC Therapeutics, Inc. | Oct 7, 20254:17 PM ET | Boulding Mark ElliottOfficer | 3.38K | $214.1K | Oct 7, 202510b5-1 | Fidelity Brokerage Services LLC | SEC |
| AXSMAxsome Therapeutics, Inc. | Oct 7, 20254:43 PM ET | Herriot TabuteauOfficer | 13.4K | $1.59M | Oct 7, 202510b5-1 | Goldman Sachs & Co. LLC | SEC |
| AXSMAxsome Therapeutics, Inc. | Oct 8, 20254:54 PM ET | Herriot TabuteauOfficer | 12.8K | $1.52M | Oct 8, 202510b5-1 | Goldman Sachs & Co. LLC | SEC |
| EXASExact Sciences Corp | Oct 9, 202511:23 AM ET | Herriott JamesOfficer | 1.50K | $90.0K | Oct 9, 202510b5-1 | Fidelity Brokerage Services LLC | SEC |
| CLGNCollPlant Biotechnologies Ltd | Oct 9, 20254:55 PM ET | Ami SagyShareholder | 140.0K | $308.0K | Oct 10, 2025 | UBS Securities LLC | SEC |
| ARTVArtiva Biotherapeutics, Inc. | Oct 17, 20254:17 PM ET | Fred AslanDirector · Officer | 25.5K | $70.6K | Oct 17, 202510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| VIRVir Biotechnology, Inc. | Oct 21, 20259:00 PM ET | SVF Endurance (Cayman) Limited10% stockholder | 834.2K | $5.23M | Oct 21, 202510b5-1 | BTIG, LLC | SEC |
| ZYBTZhengye Biotechnology Holding Ltd | Oct 22, 20254:10 PM ET | Vanguards Skyline Holdings LimitedShareholder | 2.28M | $29.4M | Nov 1, 2025 | AC Sunshine Securities LLC | SEC |
| ZYBTZhengye Biotechnology Holding Ltd | Oct 22, 20254:10 PM ET | VVAX Holdings LimitedShareholder | 685.0K | $1.79M | Nov 1, 2025 | AC Sunshine Securities LLC | SEC |
| ARQTArcutis Biotherapeutics, Inc. | Oct 28, 20254:06 PM ET | Todd F watanabeOfficer | 40.0K | $1.00M | Oct 28, 202510b5-1 | Merrill | SEC |
| UHSUniversal Health Services Inc | Oct 29, 20254:23 PM ET | Elliot SussmanDirector | 965 | $217.8K | Oct 29, 2025 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| VIRVir Biotechnology, Inc. | Nov 3, 20253:30 PM ET | de Verneuil VaninaOfficer | 1.36K | $8.00K | Nov 3, 2025 | Fidelity Brokerage Services LLC | SEC |
| ARQTArcutis Biotherapeutics, Inc. | Nov 3, 20254:52 PM ET | Howard WelgusDirector | 10.0K | $252.7K | Nov 3, 202510b5-1 | Merrill | SEC |
| ARQTArcutis Biotherapeutics, Inc. | Nov 3, 20255:47 PM ET | Patrick BurnettOfficer | 2.62K | $64.8K | Nov 3, 2025 | Merrill Lynch | SEC |
| ARQTArcutis Biotherapeutics, Inc. | Nov 3, 20255:47 PM ET | Todd Franklin WatanabeOfficer | 11.5K | $285.4K | Nov 3, 2025 | Merrill Lynch | SEC |
| ARQTArcutis Biotherapeutics, Inc. | Nov 3, 20255:48 PM ET | Latha VairavanOfficer | 88 | $2.17K | Nov 3, 2025 | Merrill Lynch | SEC |
| ARQTArcutis Biotherapeutics, Inc. | Nov 3, 20255:49 PM ET | Masaru MatsudaOfficer | 7.21K | $178.2K | Nov 3, 2025 | Merrill Lynch | SEC |
| AXSMAxsome Therapeutics, Inc. | Nov 3, 20255:56 PM ET | Herriot TabuteauOfficer | 91.7K | $12.4M | Nov 3, 202510b5-1 | Goldman Sachs & Co. LLC | SEC |
| EXASExact Sciences Corp | Nov 4, 202510:22 AM ET | Herriott JamesOfficer | 1.50K | $105.1K | Nov 4, 202510b5-1 | Fidelity Brokerage Services LLC | SEC |
| AXSMAxsome Therapeutics, Inc. | Nov 4, 20255:47 PM ET | Herriot TabuteauOfficer | 50.5K | $6.81M | Nov 4, 202510b5-1 | Goldman Sachs & Co. LLC | SEC |
| VIRVir Biotechnology, Inc. | Nov 5, 20259:47 AM ET | de Verneuil VaninaOfficer | 2.38K | $12.3K | Nov 5, 202510b5-1 | Fidelity Brokerage Services LLC | SEC |
| ARQTArcutis Biotherapeutics, Inc. | Nov 5, 20255:29 PM ET | Patrick BurnettOfficer | 3.85K | $91.2K | Nov 5, 202510b5-1 | Merrill Lynch | SEC |
| AXSMAxsome Therapeutics, Inc. | Nov 5, 20257:19 PM ET | Herriot TabuteauOfficer | 21.8K | $2.95M | Nov 5, 202510b5-1 | Goldman Sachs & Co. LLC | SEC |
| MARMarriott International Inc | Nov 6, 20253:03 PM ET | Brown William POfficer | 6.67K | $1.87M | Nov 6, 2025 | Wells Fargo Clearing Services | SEC |
| ARQTArcutis Biotherapeutics, Inc. | Nov 6, 20254:54 PM ETAmended | Todd EdwardsOfficer | 29.1K | $732.9K | Nov 6, 2025 | Merrill | SEC |
| ARQTArcutis Biotherapeutics, Inc. | Nov 6, 20255:49 PM ET | Patrick BurnettOfficer | 17.3K | $417.1K | Nov 6, 202510b5-1 | Merrill Lynch | SEC |
| MARMarriott International Inc | Nov 7, 202510:33 AM ET | Breland Benjamin T.Officer | 1.65K | $472.1K | Nov 7, 2025 | Fidelity Brokerage Services LLC | SEC |
| MARMarriott International Inc | Nov 7, 202511:20 AM ET | Reiss Rena HozoreOfficer | 5.48K | $1.57M | Nov 7, 2025 | Fidelity Brokerage Services LLC | SEC |
| MARMarriott International Inc | Nov 7, 20251:36 PM ET | Anand SatyajitOfficer | 2.74K | $787.7K | Nov 7, 2025 | Fidelity Brokerage Services LLC | SEC |
| MARMarriott International Inc | Nov 10, 202511:28 AM ET | Roe PeggyOfficer | 2.00K | $584.2K | Nov 10, 2025 | Fidelity Brokerage Services LLC | SEC |
| ADPTAdaptive Biotechnologies Corp | Nov 10, 20256:48 PM ET | Harlan RobinsOfficer | 10.0K | $147.1K | Nov 10, 202510b5-1 | Goldman Sachs & Co. LLC | SEC |
| ADPTAdaptive Biotechnologies Corp | Nov 10, 20256:48 PM ET | Chad RobinsOfficer | 86.2K | $1.27M | Nov 10, 202510b5-1 | Goldman Sachs & Co. LLC | SEC |
| ADPTAdaptive Biotechnologies Corp | Nov 12, 20258:09 AM ET | Chad RobinsOfficer | 1.24K | $18.0K | Nov 11, 202510b5-1 | Goldman Sachs & Co. LLC | SEC |
| PBYIPuma Biotechnology, Inc. | Nov 12, 20258:29 AM ET | Miller Michael PatrickDirector | 20.0K | $97.2K | Nov 11, 2025 | Fidelity Brokerage Services LLC | SEC |
| MARMarriott International Inc | Nov 12, 20259:04 AM ET | Harrison Deborah MarriottDirector · MEMBER OF A 13D GROUP | 70.0K | $20.4M | Nov 11, 2025 | HARBOR INVESTMENT ADVISORY LLC | SEC |
| ADPTAdaptive Biotechnologies Corp | Nov 12, 20254:58 PM ET | Chad RobinsOfficer | 1.88K | $27.2K | Nov 12, 202510b5-1 | Goldman Sachs & Co. LLC | SEC |
| ARQTArcutis Biotherapeutics, Inc. | Nov 13, 20254:05 PM ET | Neha KrishnamohanDirector | 40.5K | $939.3K | Nov 13, 202510b5-1 | Merrill | SEC |
| PTCTPTC Therapeutics, Inc. | Nov 17, 202510:06 AM ET | Boulding Mark ElliottOfficer | 2.81K | $210.9K | Nov 17, 202510b5-1 | Fidelity Brokerage Services LLC | SEC |
| VIRVir Biotechnology, Inc. | Nov 17, 20253:20 PM ET | O'Byrne JasonOfficer | 6.80K | $37.8K | Nov 17, 2025 | Fidelity Brokerage Services LLC | SEC |
| ARTVArtiva Biotherapeutics, Inc. | Nov 17, 20254:29 PM ET | Fred AslanDirector · Officer | 6.38K | $20.7K | Nov 17, 202510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |